Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?

This article aims to uncover the reasons for the confusion in the literature and to unravel why SGLT2i failed to succeed in COVID-19 based on some solid evidence as well as speculative and personal perspectives.PMID:38566383 | DOI:10.2174/0113816128300162240322075423

Source: Current Pharmaceutical Design - April 3, 2024 Category: Drugs & Pharmacology Authors: Medine Cumhur Cure Erkan Cure Source Type: research